Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD

por Bonaca, Marc P., Szarek, Michael, Debus, E. Sebastian, Nehler, Mark R., Patel, Manesh R., Anand, Sonia S., Muehlhofer, Eva, Berkowitz, Scott D., Haskell, Lloyd P., Bauersachs, Rupert M.
Publicado 2022

Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD

por Hess, Connie N., Baumgartner, Iris, Anand, Sonia S., Nehler, Mark R., Patel, Manesh R., Debus, E. Sebastian, Szarek, Michael, Capell, Warren, Muehlhofer, Eva, Berkowitz, Scott D., Haskell, Lloyd P., Bauersachs, Rupert M., Bonaca, Marc P., Hsia, Judith
Publicado 2022

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual antic...

por Berkowitz, Scott D., Bauersachs, Rupert M., Szarek, Michael, Nehler, Mark R., Debus, E. Sebastian, Patel, Manesh R., Anand, Sonia S., Capell, Warren H., Hess, Connie N., Hsia, Judy, Leeper, Nicholas J., Brasil, David, Mátyás, Lajos, Diaz, Rafael, Brodmann, Marianne, Muehlhofer, Eva, Haskell, Lloyd P., Bonaca, Marc P.
Publicado 2022

Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization

por Hess, Connie N., Szarek, Michael, Anand, Sonia S., Bauersachs, Rupert M., Patel, Manesh R., Debus, E. Sebastian, Nehler, Mark R., Capell, Warren H., Beckman, Joshua A., Piazza, Gregory, Henkin, Stanislav, Bura-Rivière, Alessandra, Lawall, Holger, Roztocil, Karel, Hsia, Judith, Muehlhofer, Eva, Berkowitz, Scott D., Haskell, Lloyd P., Bonaca, Marc P.
Publicado 2022